
Vaxcyte, Inc.
Vaxcyte, Inc.(PCVX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pcvx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$89.00
Consensus
$89.00
+94.8% upside
Low
$89.00
Median: $89 · Last Close: $45.69
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $44.09 | ↓ 3.50% |
1-day model range: $43.81–$44.37. Peak: $44.37 (-3.50%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $79 | +72.4% |
| 2028 | $113 | +147.3% |
| 2029 | $142 | +211.8% |
| 2030 | $165 | +260.6% |
| 2031 | — | +294.4% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PCVX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-26 | BTIG | Maintains | Buy→Buy |
| 2026-02-02 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-10 | BTIG | Maintains | Buy→Buy |
| 2025-10-16 | BTIG | Maintains | Buy→Buy |
| 2025-04-08 | Needham | Maintains | Buy→Buy |
| 2025-04-01 | Needham | Maintains | Buy→Buy |
| 2025-04-01 | B of A Securities | Maintains | Buy→Buy |
| 2025-04-01 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-03-12 | Guggenheim | Maintains | Buy→Buy |
| 2025-02-26 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vaxcyte, Inc. (PCVX) stock. Of the recent 45 rating actions, 0 were upgrades and 0 were downgrades. 11 analysts currently cover PCVX.
分析师推荐趋势
PCVX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$25M
↓ 85.9% YoY
Revenue Next Year
$87M
↑ 248.6% YoY
EPS This Year
$-8.13
EPS Next Year
$-6.67
↓ 18.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PCVX EPS of $-8.13 for the current fiscal year, based on estimates from 6 analysts. The PCVX revenue forecast is $25M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PCVX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。PCVX 的共识目标价为 $89.00(+94.8% 上行空间),分析师共识为 Buy。
PCVX 的短期预测(明日)为 $44.09(-3.50%)。 PCVX 对 2027 年的股价预测均值为 $79。 PCVX 对 2030 年的预测区间为 $153–$176。
Vaxcyte, Inc. 在 NASDAQ 上市,代码 PCVX。PCVX 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
PCVX 预测 · 8 个问题根据 11 位华尔街分析师,PCVX 的 12 个月平均目标价为 $89.00,最高 $89.00、最低 $89.00。若有图表,中位目标价可在上方查看。相对当前价 $45.69,隐含约 +94.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.